In one paragraphArticle in ASAIO journal (American Society for Artificial Internal Organs : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Jose María Arribas-LealFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.ORCID 0000-0003-3001-9960 Antonio Jiménez-AceitunaFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.ORCID 0000-0002-5763-4819 Ramón Aranda-DomeneFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.ORCID 0000-0002-6788-7668 Noelia Fernández-VillaDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.ORCID 0000-0001-6602-6762 Maydelin Lorenzo-DíazFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
José Miguel Rivera-CaravacaDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.ORCID 0000-0003-0492-6241 Julio Domingo-ZambudioService of Intensive Care & Transplant Coordination Unit, University Hospital Virgen de la Arrixaca. IMIB-Arrixaca Research Institute, Murcia, Spain.
Joaquín Pérez-AndreuFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.ORCID 0000-0003-2440-0044 Francisco J Pastor-PérezDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.ORCID 0000-0002-9818-2409 Julio García-Puente Del CorralFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.ORCID 0000-0003-3396-0844 Juan M Fernández-PérezService of Intensive Care & Transplant Coordination Unit, University Hospital Virgen de la Arrixaca. IMIB-Arrixaca Research Institute, Murcia, Spain.
Francisco Gutierrez-GarcíaFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Mario Royo-VillanovaService of Intensive Care & Transplant Coordination Unit, University Hospital Virgen de la Arrixaca. IMIB-Arrixaca Research Institute, Murcia, Spain.ORCID 0000-0002-2898-2312 Domingo A Pascual-FigalDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.ORCID 0000-0002-4993-9540 Ruben Jara-RubioService of Intensive Care & Transplant Coordination Unit, University Hospital Virgen de la Arrixaca. IMIB-Arrixaca Research Institute, Murcia, Spain.ORCID 0000-0001-8850-7233 Sergio Cánovas-LópezFrom the Department of Cardiovascular Surgery, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
Iris P Garrido-BravoDepartment of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.ORCID 0000-0002-1989-8696 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Heart transplantation using donation after circulatory death (DCD) has recently re-emerged alongside donation after brain death (DBD). This technique can potentially increase the number of available cardiac grafts. However, its clinical outcomes remain limited. We compared data from patients who received grafts from DCD versus DBD between 2012 and 2023. During this period, 131 adult patients underwent isolated heart transplantation. Of these, 25 (19%) were DCD donors. Donation after circulatory death donors were predominantly local (66% vs . 42%; p = 0.027). Donation after circulatory death graft recipients had fewer ventricular assist devices (12% vs . 35%; p = 0.025) and were less frequently urgent (12% vs . 39%; p = 0.009). Donation after circulatory death grafts had shorter myocardial ischemia and extracorporeal circulation times than DBD grafts (70 min [63.5-91] vs . 168 [83-219]; p < 0.001); (90 min [78-103) vs . 120 [96-148], p < 0.001). We observed no significant differences in the incidence of primary graft failure (16% vs . 22%; p = 0.526) or hospital mortality (8% vs . 14%; p = 0.410) between both groups. In conclusion, cardiac DCD demonstrates hospital outcomes comparable to those of cardiac DBD. Further long-term follow-up of these patients is necessary to determine their rejection, graft vascular disease, and mortality outcomes.
Indexed as
Heart TransplantationTissue and Organ ProcurementTissue DonorsAdultBrain DeathDeathFemaleHumansMaleMiddle AgedRetrospective StudiesSpaindonation after circulatory deathheart transplantationnormothermic regional perfusion
Identifiers
PMID40377428
PMCPMC12736411
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390